New Metastatic ILC Patient Advocate Representative on the PAAB

LBCA is grateful to introduce Jo Lynn Collins, who has agreed to serve as the new Metastatic ILC Patient Advocate Representative on the Patient Advocate Advisory Board (PAAB). The new role was created to ensure that the perspective of those living with metastatic invasive lobular carcinoma (mILC) is always a part LBCA’s advocacy planning. LBCA Executive Director, Laurie Hutcheson, recently interviewed Jo Lynn to learn more about all that she has been doing to raise awareness about the need for more research into mILC and support others living with it.

Jo Lynn resides in West Virginia, is a mother to two daughters, and worked as a special education teacher in the public school system before she was diagnosed with mILC, de novo (i.e., metastatic at initial diagnosis), in 2019. She explained that she initially could not find information on lobular breast cancer when she was diagnosed until she searched on the internet and found the LBCA. The struggle to find anything anywhere about lobular breast cancer motivated her to get involved to help spread awareness and information about ILC and LBCA. 

Laurie and Jo Lynn also discussed the current resources available for mILC patients through LBCA, private Facebook groups, and partnerships with ShareCancerSupport.org and BreastCancer.org including:

Share this article:
Scroll to Top

Join Us

Subscribe for the Latest News & Updates​

Join Us

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
*